BRD2 and progressive multifocal leukoencephalopathy: Furthermore, chronic NAT treatment is associated with sustained immunosuppression as well as toxicity (Edan and Le Page, 2023; Singer, 2017), specifically the development of progressive multifocal leukoencephalopathy (PML) leading to severe disability or death.